Guillain-Barré Syndrome following Treatment with Sunitinib Malate

Sunitinib malate (Sutent, SU011248) is an oral multitargeted tyrosine kinase inhibitor (TKI) used for the treatment of metastatic renal cell carcinoma and imatinib (Gleevec)—resistant gastrointestinal stromal tumor (GIST) with few reported side effects including asthenia, myelosuppression, diarrhea,...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Kanaan, Ziad, Kulairi, Zain, Titianu, Mirela, Saha, Sandip, Kumar, Sarwan
Formato: Artigo
Idioma:Inglês
Publicado em: Hindawi Publishing Corporation 2014
Assuntos:
Case Report
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4074976/
https://ncbi.nlm.nih.gov/pubmed/25018885
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2014/712040
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados